| |
| |
|
| Insider
Information: |
Bedrosian Camille L |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
207,963 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,222,498 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
207,963 |
|
|
| Total
Value |
$2,222,498 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-8.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -261.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ultragenyx Pharmaceutical Inc |
RARE |
EVP and Chief Medical ... |
2023-03-01 |
46,720 |
2018-01-30 |
0 |
Premium* |
|
|
Crinetics Pharmaceuticals, Inc. |
CRNX |
Director |
2023-06-16 |
6,000 |
2023-06-16 |
0 |
Premium* |
|
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2024-04-16 |
155,243 |
2023-11-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
31 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
47,938 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
• – – |
2018-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
18,000 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
• – – |
2021-01-15 |
4 |
AS |
$139.18 |
$3,479,500 |
D/D |
(25,000) |
35,789 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and Chief Medical Officer |
• – – |
2021-01-15 |
4 |
OE |
$55.00 |
$1,375,000 |
D/D |
25,000 |
60,789 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2023-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
58,333 |
58,333 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2024-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
96,910 |
155,243 |
0 |
- |
|
31 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
